Medical Devices Investors & VC Firms in Germany
125 firms in this list, with a median first check of $540K. 39 of them lead rounds. Generated from verified public data and updated continuously.
YZR Capital
MunichPre-Seed–Growth
12 people
MBG Mittelständische Beteiligungsgesellschaft Hamburg mbH
HamburgPre-Seed–Growth$108K – $2.7M
14 people
10x Group
MünchenSeed–Series C
6 people
Companisto
BerlinSeed$275K – $8.8M
11 people
GENIUS Venture Capital
SchwerinSeed–Series A$540K – $1.6M
4 people
SKion
Bad HomburgGrowth
9 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
10 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
Linden Capital
ChicagoPre-Seed–Series A
2 people
Target Partners
MunichSeed–Late Stage$1.1M – $3.2M
7 people
RV Invest GmbH
RavensburgSeed–Series A
8 people
Sirius Venture Partners GmbH
WiesbadenSeed–Growth$540K – $5.4M
8 people
CARMA FUND
MunichPre-Seed–Series A
5 people
Khanu
DortmundPre-Seed–Seed
7 people
Salvia
HolzkirchenSeed–Series B
4 people
Seed Fonds Aachen
AachenPre-Seed–Series A$545K – $2.2M
1 person
Bif
HamburgPre-Seed–Series A
4 people
EMBL Ventures
HeidelbergSeed–Series A$108K – $5.4M
2 people
Ventura BioMed Investors
MunichSeed–Series A$1.1M – $5.5M
2 people
S-Kap Unternehmensbeteiligungs GmbH & Co.KG
PforzheimGrowth$108K – $3.2M
3 people
Triangle Venture Capital Group
Bensheim-AuerbachSeed–Series A$1.6M – $3.2M
3 people
X2 Equity GmbH
MünchenSeed–Growth
3 people
BioScience Ventures Group AG
MunichPre-Seed–Seed$220K – $550K
2 people
Digital Health Ventures
BerlinSeed–Series A
2 people
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.






































































